You are here: Industry Insights > CF

News List

Vertex signs 'landmark' deal with NHS for CF therapy pharmatimes
July 01, 2020
Vertex has reached an agreement with NHS England to reimburse its triple combination therapy Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor), should the medicine win European approval.
AR-501 Enrolls First Subject in Trial for Treatment of CF Chronic Lung Infections americanpharmaceuticalreview
December 13, 2018
Aridis Pharmaceuticals announced the first subject has been enrolled in a Phase 1/2a clinical study evaluating the investigational candidate AR-501 for treatment of chronic bacterial lung infections in patients with cystic fibrosis (CF).....
Vertex told to reveal CF drug price, as MPs begin inquiry pharmaphorum
December 04, 2018
UK politicians could go public with the price of Vertex’s cystic fibrosis drug Orkambi, if the company does not strike a deal giving NHS patients access by the end of the month.
PARI Devices Used in SHIP Study of Hypertonic Saline in Preschoolers with Cystic Fibrosis americanpharmaceuticalreview
November 30, 2018
A recent study in preschoolers with cystic fibrosis (CF) conducted by Cystic Fibrosis Foundation Therapeutics used PARI's LC Sprint Jr. nebulizer, Vios PRO compressor.....
AbbVie assumes full development and commercial control of CF programme pharmatimes
November 01, 2018
AbbVie has announced that it will assume full development and commercial responsibility for its collaboration with Galapagos to discover and develop new therapies to treat cystic fibrosis (CF).
Test for antibiotic associated kidney damage in children with CF identified europeanpharmaceuticalreview
April 02, 2018
New research highlights effective methods for identifying a common side effect in children receiving drug treatments for Cystic fibrosis…

Previous page 1 2 Next page